A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Lafayette scandal's Kuo Li-heng dies at 73
07/10/2025 10:13 PM - Culture
National Cultural Award presented to 3 masters in various fields
07/10/2025 09:31 PM - Politics
No plan to greenlight aid for Taipower: KMT Chair
07/10/2025 09:24 PM - Society
Power restored for 94% of homes hit by typhoon-caused record damage
07/10/2025 07:55 PM - Politics
Referendum, 26 recall votes could cost up to NT$1.62 billion: CEC
07/10/2025 07:42 PM